Genetic Counseling
Initial evaluation of family history and selection of the appropriate PGT type.
Genomic Precision at Gynatal Timișoara
We categorize genetic testing based on the specific reproductive risk identified during the Genetic Counseling phase:
This is a general screening of all 24 chromosomes to identify embryos with the correct number (euploid). It is essential for managing age-related fertility decline, where chromosomal errors (aneuploidies) are the leading cause of implantation failure.
Targeted testing used when one or both partners are carriers of a specific single-gene mutation, such as Cystic Fibrosis, Spinal Muscular Atrophy (SMA), or Huntington’s Disease. It ensures only unaffected embryos are selected for transfer.
Recommended for couples where a parent carries a balanced translocation or inversion. This testing identifies embryos with unbalanced chromosomal structures that would otherwise result in miscarriage.
Initial evaluation of family history and selection of the appropriate PGT type.
Embryos are grown to the blastocyst stage (Day 5 or 6), where they consist of 100–150 cells and have higher implantation potential.
Utilizing Next-Generation Sequencing (NGS) to read the genetic code with maximum precision.
Embryos are vitrifiedusing validated protocols with excellent post-warming survival rates
When applicable, a chromosimally normal embryo is selected for transfer during an optimized Frozen Embryo Transfer (FET).
Data suggests that PGT is not a universal requirement but is highly beneficial for:
Advanced Maternal Age (>35-37): To mitigate the natural decline in oocyte quality.
Repeated Implantation Failure (RIF): After two or more unsuccessful transfers.
Recurrent Pregnancy Loss: Identifying "invisible" chromosomal factors behind consecutive miscarriages.
Severe Male Factor: Where sperm parameters are significantly compromised.
Previous embryo aneuploidy / known chromosomal rearrangements
While PGT cannot guarantee a successful pregnancy, it can significantly increase the likelihood of achieving a healthy live birth per embryo transfer and may reduce the risk of miscarriage associated with chromosomal abnormalities.